Background/Aims: The atherosclerotic apolipoprotein E-deficient (apoE -/-) mouse exhibits impaired vasodilation and enhanced vasoconstriction responsiveness. The objectives of this study were: a) to determine the relative contribution of cyclooxygenases (Cox-1 and Cox-2), thromboxane A2 (TXA2) and endothelin-1 (ET-1) to enhancing vascular hyperresponsiveness in this model of atherosclerosis and b) to investigate the beneficial effects of the phosphodiesterase 5 inhibitor sildenafil on this endothelial dysfunction. Methods: Adult male apoE -/-mice were treated with sildenafil (40 mg/kg/day, for 3 weeks) and compared with nontreated ApoE -/-and wild-type mice. The beneficial effects of sildenafil on vascular contractile response to phenylephrine (PE) in aortic rings were evaluated before and after incubation with Cox-1 (SC-560) or Cox-2 (NS-398) inhibitors or the TP antagonist SQ-29548, and on contractile responsiveness to ET-1. Results: ApoE -/-mice exhibited enhanced vasoconstriction to PE (R max ~35%, p<0.01), which was prevented by treatment with sildenafil. The enhanced PE-induced contractions were abolished by both Cox-1 inhibition and TP antagonist, but were not modified by Cox-2 inhibition. Aortic rings from ApoE -/-mice also exhibited enhanced contractions to ET-1 (R max ~30%, p<0.01), which were attenuated in sildenafil-treated ApoE -/-mice. In addition, we observed augmented levels of vascular proinflammatory cytokines in ApoE -/-mice, which were partially corrected by treatment with sildenafil (IL-6, IL-10/IL-6 ratio and MCP-1). Conclusion: The present data show that the Cox-1/TXA2 pathway prevails over the Cox-2 isoform in the mediation of vascular hypercontractility observed in apoE -/-mice. The results also show a beneficial effect of sildenafil on this endothelial dysfunction and on the proinflammatory cytokines in atherosclerotic animals, opening new perspectives for the treatment of other endothelium-related cardiovascular abnormalities.
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Introduction
Atherosclerosis (AT) is a complex vascular inflammatory disease of conductance arteries and its subclinical condition is an important trigger of future unfavorable cardiovascular outcomes, such as cerebrovascular events or acute myocardial infarction [1] [2] [3] [4] . It is initiated and sustained by a combination of endothelial dysfunction and chronic exposure to modifiable risk factors (e.g. inadequate lifestyle) and non-modifiable risk factors (e.g. aging and male gender), which have been widely demonstrated by experimental [2, [5] [6] [7] [8] and clinical studies [9] [10] [11] [12] .
In the last three decades, genetically modified mice have been extensively used as models for understanding the causes and mechanisms involved in human diseases and have contributed to the consolidation of translational research in cardiovascular and metabolic disorders [5, 7, 8, 13, 14] . Among the available models, the apoE -/-mouse was the first and most widely used for this purpose. Loss of apoE gene expression in this animal compromises the hepatic clearance of VLDL and LDL, leading to spontaneous hypercholesterolemia [1, 3, 7] . Moreover, apoE -/-mice exhibit impaired vasodilation and enhanced vasoconstriction responsiveness, which are hallmarks of endothelial dysfunction in this experimental model and in atherosclerotic humans [4, 5, 7] . Previous studies have contributed to understanding of the mechanisms of impaired relaxation of both resistance and conductance vasodilation in the apoE -/-mouse [7, 15] . However, the mechanisms underlying vascular hypercontractility, and approaches to correct this disturbance in this model, have not yet been completely elucidated. Thus, there is a need for research into putative therapies to treat and prevent the vascular endothelium-dependent hypercontractility that is commonly observed in chronic cardiovascular diseases, including AT.
More recently, our laboratory and others have investigated some mechanisms for the progression of AT, and alternative strategies to improve endothelial function using the apoE -/-model [5, 7, [15] [16] [17] . In this context, we and others have previously shown that the decreased endothelium-dependent vasodilation response to acetylcholine observed in this atherosclerotic model is mainly due to decreased bioavailability of nitric oxide, increased production of reactive oxygen species (ROS) and chronic inflammation [7, 15, 16, 18, 19] . In addition, we demonstrated an exacerbated vasoconstrictor response to sympathetic agonists in the same experimental model, with relative contribution of eicosanoids and ROS using nonselective cyclooxygenase (Cox-1/Cox-2) and NADPH oxidase inhibitors, respectively [18, 20] . In parallel, our laboratories [15, 18, [21] [22] [23] and others [24, 25] have published several data supporting the idea that chronic use of sildenafil, a phosphodiesterase 5 (PDE5) inhibitor, improves endothelial function in the apoE -/-mouse. However, the beneficial effects of this drug on the prostanoid vasoconstrictors and on inflammatory cytokines have not yet been evaluated in this suitable animal model of AT [26, 27] .
The present study was therefore designed to determine whether the exaggerated contractile response observed in conductance vessels from apoE -/-mice could be mediated by: 1) eicosanoids derived from COX-1 or COX-2) pathways, 2) enhanced responsiveness to endothelin 1 (ET-1) and 3) aortic ROS overproduction. The hypotheses that inflammatory cytokines play a pivotal role, and that sildenafil is able to attenuate or abolish those endothelial dysfunctions, were also tested.
Materials and Methods
Animals
The experiments were conducted in adult (18-week-old) male apoE -/-mice that had a C57BL/6J genetic background, and in wild-type (WT) mice. The animals were bred and maintained in the animal care facility at the Laboratory of Translational Physiology of the Health Sciences Center of the Federal University of Espírito Santo, Brazil. The mice were housed in individual acclimatized plastic cages with temperature control (22-23°C) and humidity (60%) and were exposed to a 12/12-h light-dark cycle. All experimental procedures were performed in accordance with the guidelines for the care and handling of laboratory animals as recommended by the National Institutes of Health (NIH), and the study protocols were approved by the Institutional Animal Care Committee (CEUA).
To accelerate the spontaneous hyperlipidemia and the progression of endothelial dysfunction and AT, the apoE -/-animals were fed a Western-type diet for 10 weeks, beginning at 8 weeks of age. After 7 weeks (15-week-old), the apoE -/-mice were divided into the following groups: a) apoE -/-mice treated with the PDE5 inhibitor, sildenafil (Viagra®, 40 mg/kg/day, for 3 weeks, by oral gavage), and b) apoE -/-mice treated with the vehicle. Wild-type mice were used as negative controls.
Plasma lipids profile
Blood samples were obtained by puncturing the animals' right ventricles, after euthanization with an overdose of sodium thiopental (Cristalia, Sao Paulo, Brazil, 200 mg/kg, i.p.). The blood was immediately transferred to a tube containing heparin and centrifuged at 956 g for 10 min. Plasma was separated immediately and kept at −20 °C until assayed. The levels of total plasma cholesterol, high density lipoproteins (HDL) and triglycerides were measured using commercial colorimetric assay kits (Bioclin, Belo Horizonte, Brazil). The levels of non-HDL were estimated by subtracting HDL from total serum cholesterol.
Vascular function
At the end of the treatment, animals were euthanized as previously described (see above) and the descending thoracic aorta was carefully excised by midline abdominal incision, and cleaned of fat and connective tissue, taking care to do not stretch the vessel excessively to ensure the integrity of the endothelium. Next, the aorta was then cut into small rings (~ 3 mm length) and placed in cold KrebsHenseleit buffer with the following composition (in mM): NaCl 115, KCl Aortic rings were then mounted on stainless steel triangles, suspended in vertical organ baths containing 5 mL Krebs solution, maintained at a resting tension of 0.5 g at 37°C, pH 7.4 and continuously gassed with a mixture of 95% O 2 and 5% CO 2 . The rings were connected to force transducers to measure isometric tension using a computerized acquisition system (MP100, Biopac Systems Inc., Santa Barbara, USA).
After a 60-min equilibration period, aortic rings were exposed to KCl (125 mM) to assess their maximal tension. After washout (30 min), aortic rings pre-contracted with the α-agonist phenylephrine (PE, 10 µM) were challenged with the vasodilator acetylcholine (10 μM). Relaxing responses greater than 60% indicated the presence of intact endothelial cells [18] . After washout with fresh buffer solution (30 min) and an equilibration period for 30 minutes, the contractile responsiveness of aortic rings was tested through cumulative concentrations of PE (from 100 pM to 30 mM).
To evaluate the relative contribution of endothelium-derived vasoactive factors to hypercontractile responsiveness, we initiated contractile response analyses. Thus, after another washout, the contractile responses of aortic rings to PE were repeated, after previous incubation for 20 min with one of the following agents: a) selective Cox-1 inhibitor (SC-560, 1 μM), b) selective Cox-2 inhibitor (NS-398, 1 μM) or c) thromboxane-prostanoid receptor (TP) antagonist (SQ 29548, 1 μM).
The curve-concentration responses were analyzed based on the calculation of the a) area under the curve (AUC) when testing the responsiveness to PE or endothelin 1, or the difference in the area under the curve (∆ AUC), when comparing concentration-response curves to PE before and after an inhibitor, expressed in arbitrary units (a.u.), b) the sensitivity of aortic rings to PE or endothelin 1, which was estimated using the pEC 50 (−log EC 50 ) and c) the efficacy estimated using the maximum response (R max ) to PE or endothelin 1 in both conditions.
Contribution of oxidative stress to enhanced contractile vascular responsiveness
At the end of the treatment, the lucigenin-derived chemiluminescence assay was used to determine superoxide anion (•O 2 -) levels in the aorta. Isolated vascular ring segments (3 mm), obtained as described in the previous section were acutely incubated in saline phosphate buffer. Luminescence was quantified in a luminometer (Orion II luminometer, Berthold Detection Systems, Pforzheim, Germany) and the results are expressed as percentage of control group (arbitrary units).
Determination of cytokines in aortic tissue using cytometric bead array
The levels of inflammatory interleukin 6 (IL-6) chemokine (MCP-1) and tumor necrosis factor alpha (TNF-α) cytokines, and the anti-inflammatory IL-10 cytokine were measured in the aortic tissue by flow cytometry using a cytometric bead array, according to the manufacturer's instructions described in a mouse inflammation Kit, (CBA -BD Biosciences, San Diego, CA, USA). The BD CBA system uses the sensitivity of amplified fluorescence detection by flow cytometry to measure different soluble analytes in a particlebased immunoassay in a single sample. Based on the manufacturer's recommended procedure, a typical forward and side scatter gate was set to exclude aggregates; a total of 5, 000 events in the gate were analyzed using FACSCanto II and FACSDiva Software (BD). Samples were quantified by comparing them with standard curves of recombinant cytokines using FCAP Array software (BD). The results are expressed as pg/mL.
Statistical analysis
The values are expressed as means±SEM. The Gaussian distribution of the variables was previously analyzed using the D' Agostino-Pearson omnibus normality test. Fitting concentration-response curves were constructed and analyzed using nonlinear regression analysis. Statistical comparisons between the different groups were performed by one-or two-way analysis of variance (ANOVA), followed by Bonferroni's post hoc test. Differences between means with a value of p<0.05 were considered statistically significant. Statistical software: Prism 7.0, GraphPad Software Inc.
Results
Plasma lipid profiles
The plasma lipid profiles of the three groups of animals are summarized in Table 1 . ApoE -/-mice showed a significant increase in triglycerides (~3-fold, p<0.001), total plasma cholesterol (~14-fold, p<0.001) and non-HDL (~28-fold, p<0.001), and the treatment with sildenafil did not modify these differences in relation to the wild-type group. As expected, HDL was significantly reduced (~2-fold, p<0.001) in both the non-treated and the sildenafiltreated apoE -/-groups, compared with wild-type mice. Fig. 1 summarizes the results of the evaluation of PE-induced contractions in aortic rings from the apoE -/-and wild-type groups. As shown in the line-graph, the apoE -/-group exhibited a left-and upward-shift in the concentration-response curve to PE when compared with the wild-type animals (p<0.05), indicating an enhanced contractile responsiveness in those atherosclerotic animals. In contrast, the curve of apoE -/-mice treated with sildenafil was right-and downward-shifted, close to the concentration-response curve of wild-type mice. Accordingly, apoE -/-mice exhibited a significant increase in efficacy (R max ~35%, p<0.01), sensitivity (~7%, p<0.01) and AUC (~44%, p<0.01) when compared with wild-type mice, and the treatment with sildenafil completely supressed these parameters (R max : 31%, sensitivity: 7% and AUC: 39%, p<0.05 vs apoE -/-mice; p>0.05 vs. wild-type mice) as demonstrated in the table at the bottom of Fig. 1 .
Contractile response to α1-adrenoceptor stimulation
Contribution of the cyclooxygenase-2 pathway to enhanced contractility
Following the demonstration of an exacerbated vasoconstriction to PE in apoE -/-mice, we focused our analysis on the contribution of the prostanoid molecular pathway in this abnormal response. The average data of concentrationresponse curves to PE and the respective parameters are shown in the line-graphs and in the bottom table in Fig. 2 , comparing the PE-induced values before and after the specific Cox-2 blockade with NS-398 in the three groups of animals. No significant differences were observed in the concentration-response curves (line-graphs) or in the parameters of the curves (bottom upward shift (p>0.05) in the curves, indicating a worsening of contractile hyperresponsiveness to PE in the apoE -/-group. In the group apoE -/-mice, in which hypercontractility to PE had been normalized by the treatment with sildenafil, pre-incubation with the NS-398 inhibitor did not cause additional significant changes in the concentration-response curves when compared with the data obtained without the Cox-2 blockade. These data suggest that the Cox-2-derived pathway does not contribute to the vascular hyperresponsiveness exhibited by apoE -/-mice.
Contribution of the cyclooxygenase-1 pathway to hypercontractility responsiveness
Next, we evaluated the relative contribution of Cox-1 to this process in a different group of animals, using SC-560, a specific inhibitor of this pathway. As indicated in the upper panel graphs and in the respective parameters in the bottom table (Fig. 3) , pre-incubation of aortic rings with the Cox-1 inhibitor did not modify the curve parameters in the wild-type group. However, this blockade caused a right-and downward shift in the concentration-response curve to PE in aortic rings from apoE -/-mice (line-graph of Fig. 3) . Accordingly, the maximum response (R max ) was significantly reduced (39%, p<0.05) and consequently the difference in AUC was significantly augmented (2.7-fold, p<0.05) when compared with the wild-type group. In contrast, pre-incubation of aortic rings with the Cox-1 inhibitor did not cause significant effects on the parameters of the concentration-response curves of apoE -/-mice treated with sildenafil, in which treatment with sildenafil had already normalized the concentrationresponse curve to PE.
Contribution of TXA 2 to enhanced contractile responsiveness
Next, we evaluated the contribution of TXA2 to hyperresponsiveness in the vasoconstrictor PE in aortic rings from apoE -/-mice. Fig. 4 , shows the average data of 
concentration-response curves to PE under the effect of the TP antagonist SQ-29.548 (1 μM) in the three groups of animals. As indicated in the upper panel graphs and in the respective parameters in the bottom table, pre-incubation of aortic rings with the TP antagonist did not modify the sensitivity in the previous response to PE in the three groups of animals (p>0.05). However, in terms of R max and AUC, a reduction in the concentration-response curve to PE was observed. For instance, when we compared the AUC in the presence and absence of blockade as demonstrated in Fig. 4 , a minor reduction was noted in the wild-type group (-17% p<0.05), but this reduction was significantly greater in the apoE -/-mice (-26 % p<0.05). Interestingly, treatment with sildenafil normalized this parameter (-18 % p<0.05). On the other hand, the R max to PE under the TP blockade was significantly decreased in apoE -/-mice (-23%, p <0.05), but it was not significant either in wild-type (-14% p>0.05) or 50 and R max ), and oneway ANOVA (∆AUC). in apoE -/-mice treated with sildenafil (-8%, p>0.05).
Contractile vascular responsiveness to endothelin-1
Having established that both Cox-1 and the TXA2 pathways have an important relative contribution to the vascular hypercontractility to PE in apoE -/-mice, we decided to evaluate the role of the endogenous vasoconstrictor endothelin-1. Fig. 5 summarizes the results of the evaluation of endothelin-induced contractions in aortic rings from all groups. As expected, aortic rings of apoE -/-animals exhibited an enhanced contractile response to endothelin-1 when compared with wild-type animals, as indicated by the three main concentrationresponse curve parameters (bottom of Fig.  5 ). The data showed a significant increase in efficacy (~68%), sensitivity (~7%) and AUC (~2-fold) in apoE -/-mice when compared with wild-type mice (p<0.05). Looking at figure 5, we see that among the three parameters of the curve response to endothelin-1, the one most affected by sildenafil treatment was R max (-32%p<0.05), with small changes in all other parameters.
Contribution of oxidative stress to enhanced contractile vascular responsiveness
We also evaluated the oxidative stress by measuring •O 2 -, the most important ROS. Fig. 6 shows the production of •O 2 -generated in the three groups of animals, which was significantly augmented in aortas from apoE -/-(2.6-fold, p<0.05) when compared with wild-type control animals. In the group of apoE -/-treated with sildenafil, the levels of •O 2 -were attenuated 1.7-fold (p<0.05).
Aortic inflammatory cytokines
In a separated group of animals, we evaluated the levels of proinflammatory IL-6, MCP-1 and TNF-α cytokines, and the antiinflammatory IL-10 cytokine in aortic tissue. As expected and as shown in Fig. 7 , aortas from apoE -/-mice showed augmented levels of the proinflammatory cytokine IL-6 (3-fold, p<0.05) when compared with wild-type mice, and this difference was significantly attenuated by chronic treatment with sildenafil (1.6-fold, p<0.05). Although no significant changes in the anti-inflammatory IL-10 were observed when compared with the wild-type group, the apoE -/-mice exhibited a significant reduction in the IL-10/IL-6 ratio aortic chemokine TNF-α was also significantly augmented in apoE -/-mice (1.2-fold, p<0.05), and the treatment with sildenafil did not have significant effects. The level of tissue cytokine MCP-1 was also significantly augmented (2-fold, p<0.05) and this difference was attenuated with chronic treatment with sildenafil (1.6-fold, p<0.05).
Discussion
This study was designed to elucidate the mechanisms involved in the vascular hypercontractility of aortic rings from apoE -/-mice and to test the beneficial effects of the PDE 5 inhibitor sildenafil on this abnormal response. Our data show a hyperactivation of COX-1/ TXA2 pathway and an exacerbated contractile response to ET-1 beyond the increased levels of proinflammatory cytokines and •O 2 -. Interesting that the exacerbation of these four different but complementary pathways was successfully attenuated by sildenafil, reinforcing the vascular protective effects exhibited by this PDE5 inhibitor.
In the present study, we observed a hypercontractility in aortic rings from apoE -/-, which is in agreement with previous data from our laboratory [18] and with other studies that have observed enhanced vasoconstrictions even in apoE +/-, a model of mild dyslipidemia [28] . Data from previous studies suggest that the exacerbated vascular contractile response to α1-adrenoceptor agonists, which was observed in the apoE -/-murine model, could be mediated by altered vascular responsiveness to endogenous vasoconstrictors and an imbalance of the vasodilatory/vasoconstriction prostanoid pathways [18, 20] . It has also been suggested that this hypercontractile response to phenylephrine (R max ) is due to higher levels of cytosolic Ca 2+ concentration ([Ca   2+ ] c ) in the smooth muscle cells of apoE -/-mice [29] . Accordingly, it has been established that Cox-derived pro-inflammatory prostanoids play a pivotal role in the generation of endothelial dysfunction and AT [26, [30] [31] [32] . Cox-1 and Cox-2 convert arachidonic acid to final vasoactive prostanoids, including balanced actions of PGI 2 and TXA2 to maintain the regulation of vascular function [33] . In general, Cox-1 is constitutively expressed in most tissues, whereas Cox-2 is an inducible isoform by various physiological stimuli such as inflammation and shear stress [34] [35] [36] [37] [38] . However, few studies have been conducted to evaluate the role of these endothelial enzymes in the apoE -/-murine model. Therefore, the novelty of the present study includes the elucidation of the relative role of Cox-1 and Cox-2 mediating the hypercontractility induced by phenylephrine, and the pleiotropic effects of the PDE-5 inhibitor sildenafil on the Cox-1 and Cox-2 pathways.
The activation of Cox, the diffusion of endothelium-dependent contracting factors towards the smooth muscle cells, and the subsequent stimulation of their TP are important contributors to endothelial dysfunction [39] . In apoE -/-mice, in which elevated production of TXA2 [34] has been observed, interruption of TXA2 signaling by deletion of its receptor (TP) limits atherogenesis [40] . By using the specific inhibitors SC-560 for Cox-1 and NS-398 inhibitor for Cox-2 ( Fig. 3) , we observed that Cox-1 prevails over Cox-2 in the mediation of the endothelium-dependent vasoconstrictor response to PE apoE -/-mice. This is in agreement with the finding that aortic endothelial cells preferentially express Cox-1 versus Cox-2 [31, 41] , and that as Cox-1 expression is increased, the major source of vasoconstrictor prostanoids is converted into the endothelial cells, which diffuse to contract the underlying vascular smooth muscle in arteries of mouse models of cardiovascular diseases [31, 42] . Importantly, chronic treatment with sildenafil normalized the vascular hypercontractility (R max ) in this model of AT. Interestingly, pre-incubation of the aortic rings with the TXA 2 inhibitor SQ-29548 (data in Fig. 4 ) reduced hypercontractility to PE to a similar extent to that observed when the aortic rings were pre-incubated with a specific Cox-1 inhibitor. Therefore, using different protocols, our data indicate that Cox-1, but not Cox-2 is an important contributor to the endothelium-dependent hypercontractility observed in the apoE -/-mouse model of AT, which is in agreement with other studies [40] . The present data is also corroborated by other studies that show that activation of TP is of high relevance for vasoconstriction [26, [43] [44] [45] [46] , and that the pharmacological antagonism of TXA 2 can delay the progression of AT [47, 48] . This could be explained by the fact that the activation of TP lead to the increase in [Ca +2 ] c , a critical step for vasoconstriction and the atherosclerotic process [18, 49, 50] . In addition, other studies have shown that TXA2 up-regulates NADPH oxidase [42, 51, 52] , increasing the levels of superoxide anion, which reacts with NO, compromising its bioavailability and its vasodilator activity. This hypothesis is supported by the present data showing a significant increase (more than 2-fold) of superoxide anions in aortic tissue of apoE -/-mice (Fig. 6 ). The novelty of the present study is the demonstration that sildenafil treatment was able to correct the Cox-1/TXA2 pathway disturbance. However, one cannot rule out the participation of other endothelium-derived vasocontractile agents.
We also considered a possible contribution of ET-1 to the hyperreactivity in this atherosclerotic model. This peptide is a potent vasoconstrictor that is continuously secreted by vascular endothelial cells and acts on the underlying smooth muscle cells through ET A receptors that increase [Ca +2 ] c , [53] [54] [55] [56] , potentiating the TXA 2 pathway. It has been associated with many forms of cardiovascular disease [57, 58] . Based on this concept, and considering the evidence that conductance vessels from atherosclerotic apoE -/-mice exhibit an overproduction of ET-1 and ETA hypersensitivity [58] [59] [60] , we evaluated the responsiveness in aortic rings from apoE -/-to ET-1. Our data show an exacerbated vascular contractile response to ET-1 in apoE -/-mice, which could also contribute (via NADPH oxidase) to the overproduction of •O 2 -and to the increased degree of endothelial dysfunction [53, 61] that we observed in the present study. Moreover, it has been shown that activation of Cox is a source of •O 2 -because of its ability to co-oxidize substances such as NADPH [36] , which corroborates the present study. Therefore, our cumulative findings show an overproduction of vascular ROS (Fig. 6) , an exacerbated contraction force of aortic rings to TXA2 (Fig. 4) and enhanced response to ET-1 (Fig. 5 ) in apoE -/-mice. This led us to determine whether sildenafil could minimize these synergic mechanisms in the progression of endothelial dysfunction.
Recent data have demonstrated that •O 2 -may upregulate PDE4 and PDE5, which rapidly inactivates the second messengers involved in vasodilation such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) [15, 18, 62] . Additionally, superoxide anions appear to stimulate the production of TXA2 and 8-isoprostane, an equipotent agonist of TP [52, 62] and ET-1 [63, 64] . Thus, pharmacological strategies such as pleiotropic drugs to interrupt this vicious cycle cascade seem to be relevant against AT. In fact, in the present study we observed that treatment of apoE -/-animals with this PDE5 inhibitor reduced the vascular hyperactivity probably by decreasing the TP/ET-1/NADPH oxidase activity. Previous reports from our laboratory and other studies have revealed that sildenafil, besides having vasodilatory effect (by preserving cGMP signaling and consequently reducing [Ca +2 ] c ) presents additional anti-atherosclerotic effects, such as: exhibiting indirect antioxidative and antigenotoxic activity [15, 21, 23] , increasing the number and function of endothelial progenitor cells [21] , and reducing significantly lipid deposition in the ] c in smooth vascular muscle cells by increasing cGMP, correcting this abnormal pathway; 2) reduction of levels •O 2 -, restoring the bioavailability of NO and lastly (and most surprisingly) the reduction of proinflammatory IL-6, TNF-α and MCP-1 (important stimulators of ROS) [8, 19, [65] [66] [67] . In addition to the data relating to changes in vascular inflammatory cytokines, we are demonstrating, for the first time, evidence of an anti-inflammatory effect of sildenafil in atherosclerotic apoE -/-mice (Fig. 7) . AT is characterized by chronic inflammation and enrichment of inflammatory cells in the vessel wall [39] . The crucial role of pro-inflammatory cytokines (e.g., MCP-1, TNF-α and IL-6) in the initiation and progression of AT is well documented [8, 28, [65] [66] [67] . However, there are many challenges when studying the immune system in mice aortic tissues, due to the size and the number of cells obtained from the aorta. As a solution, techniques such as polymerase chain reaction and immunohistochemistry can be useful, although they also have some limitations, such as poor correlation between mRNA and protein and semi-quantitative data, respectively [68] [69] [70] .
In this study, we demonstrated, for the first time, an increase of IL-6, TNF-α and MCP-1 proteins in aortas of apoE -/-mice using the cytometry assay (Fig. 7) . The observation that the ratio antiinflammatory/proinflammatory cytokines was markedly reduced in the atherosclerotic animals and significantly attenuated by the treatment with sildenafil was also important. Previous studies have shown that MCP-1 plays an important role in the recruitment and trans-endothelial migration of monocytes in early atherogenesis [1, 71, 72] . At the same time, IL-6 is an important biomolecule that increases the oxidative stress, promotes fatty streaks and induces leukocytes recruitment into the sub-endothelial space [65, 73] . This led us to propose that the reduction of pro-inflammatory mediators by sildenafil might be justified by an increase in cGMP. This possibility is supported by previous findings in other experimental models demonstrating that intracellular cGMP diminishes cytokine production and oxidative stress, thereby modulating the inflammatory response [74] [75] [76] .Therefore, it seems reasonable to consider that the correction of the enhanced contractile responsiveness promoted by sildenafil in aortic rings from apoE -/-mice could act, at least in part, via its antioxidant properties and indirect interaction with pro-inflammatory mediators, highlighting the benefits of the pleiotropic effects of sildenafil, as observed in other experimental models [4, 22] .
Conclusion
A schematic summary of the present data is shown in Fig. 8 . Our data show that the enhanced vasoconstriction of aortic rings from atherosclerotic mice is mediated by Cox-1 (but not Cox-2) via thromboxane A2 and ET-1, which can be repaired by sildenafil, 
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